减少不必要的甲状腺活检并提高诊断准确性:迈向「正确」的TIRADS
应用各系统FNA标准可减少17.1%至53.4%的活检,其中ACR TIRADS减少最多(502例中268例)且假阴性率最低(NPV 97.8%,95%CI 95.2%-99.2%)。结论认为ACR TIRADS表现最优。
要点
- 应用超声风险分层系统可减少17.1%-53.4%的甲状腺结节活检。
- ACR TIRADS减少活检最多(268/502)且假阴性率最低(2.2%)。
- 除韩国甲状腺放射学会TIRADS外,其他系统均显示显著判别性能。
核心结论
- 国际认可的超声风险分层系统在减少不必要甲状腺结节FNA方面的能力差异很大。
- ACR TIRADS表现优于其他系统,将超过一半的活检归类为不必要,假阴性率为2.2%。
研究设计与样本
- 单中心学术转诊中心设置。
主要发现
- 应用各系统FNA标准可减少17.1%至53.4%的活检。
- ACR TIRADS减少活检最多(502例中268例),假阴性率最低(NPV 97.8%,95%CI 95.2%-99.2%)。
- 除韩国甲状腺放射学会TIRADS外,其他系统均显示显著判别性能,但活检减少幅度显著更小。
关键数值与推荐
- ACR TIRADS:减少268/502例活检,NPV 97.8%(95%CI 95.2%-99.2%),假阴性率2.2%。
- 各系统FNA标准减少活检范围17.1%至53.4%。
临床怎么用
- 临床可采用超声风险分层系统作为「排除」测试,识别可安全推迟FNA的甲状腺结节。
- ACR TIRADS在减少不必要活检方面表现最优,可优先考虑用于风险分层。
局限性
- 单中心学术转诊中心研究,结果外推需谨慎。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The prevalence of thyroid nodules in the general population is increasingly high, and at least half of those biopsied prove to be benign. Sonographic risk-stratification systems are being proposed as "rule-out" tests that can identify nodules that do not require fine-needle aspiration (FNA) cytology. OBJECTIVE: To comparatively assess the performances of five internationally endorsed sonographic classification systems [those of the American Thyroid Association, the American Association of Clinical Endocrinologists, the American College of Radiology (ACR), the European Thyroid Association, and the Korean Society of Thyroid Radiology] in identifying nodules whose FNAs can be safely deferred and to estimate their negative predictive values (NPVs). DESIGN: Prospective study of thyroid nodules referred for FNA. SETTING: Single academic referral center. PATIENTS: Four hundred seventy-seven patients (358 females, 75.2%); mean (SD) age, 55.9 (13.9) years. MAIN OUTCOME MEASURES: Number of biopsies classified as unnecessary, false-negative rate (FNR), sensitivity, specificity, predictive values, and diagnostic ORs for each system. RESULTS: Application of the systems' FNA criteria would have reduced the number of biopsies performed by 17.1% to 53.4%. The ACR Thyroid Imaging Reporting and Data System (TIRADS) allowed the largest reduction (268 of 502) with the lowest FNR (NPV, 97.8%; 95% CI, 95.2% to 99.2%). Except for the Korean Society of Thyroid Radiology TIRADS, all other systems exhibited significant discriminatory performance but produced significantly smaller reductions in the number of procedures. CONCLUSIONS: Internationally endorsed sonographic risk stratification systems vary widely in their ability to reduce the number of unnecessary thyroid nodule FNAs. The ACR TIRADS outperformed the others, classifying more than half the biopsies as unnecessary with a FNR of 2.2%.
引用
- Grani G, Lamartina L, Ascoli V, et al. Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADS. J Clin Endocrinol Metab. 2019. PMID: 30299457. doi:10.1210/jc.2018-01674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。